BETAAccess all features while we're in beta! Some features may become paid later.Send feedback →
vpside

CDNA

CareDx, Inc.
Nasdaq · Services · Medical laboratories (SIC 8071) · FY ends 31 Dec

Revenue, quarterly

$139M+39.3% year on year
$150M$100M$50M$0
Q4 ’21Q1 ’23Q2 ’24Q2 ’25Q3 ’26
Company filings · 10-Q filed 29 Oct 2026 · Q4 = FY − 9Mvpside.com

Gross margin, trailing twelve months

65.5%+5.3 pp year on year
100%80%60%40%
Q3 ’15Q4 ’16Q1 ’18Q1 ’19Q2 ’20
Company filings · 10-Q filed 4 Aug 2020 · TTM = last four quartersvpside.com

Cash and cash equivalents, quarter-end

$250M+173.9% year on year
$400M$200M$0
Q4 ’21Q1 ’23Q2 ’24Q2 ’25Q3 ’26
Company filings · 10-Q filed 29 Oct 2026 · balance sheet, period-endvpside.com

Free cash flow, trailing twelve months

−$2M
$10M$0−$10M−$20M−$30M
Q3 ’15Q3 ’16Q3 ’17Q3 ’18Q3 ’19
Company filings · 10-Q filed 29 Oct 2020 · TTM = last four quartersvpside.com
Chart 05 is empty
Chart 06 is empty